Lead Optimization toward Proof-of-Concept Tools for Huntington’s Disease within a 4-(1H-Pyrazol-4-yl)pyrimidine Class of Pan-JNK Inhibitors.

Details

Language :

English

ISSN :

00222623

Volume :

58

Issue :

7

Database :

Supplemental Index

Journal :

Journal of Medicinal Chemistry

Publication Type :

Academic Journal

Accession number :

102002622

Full Text :

https://doi.org/10.1021/jm5013598